Market Cap
₹15,750 Cr.
P/E
28.68
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

12 Yes

Positive for this company

1 Neutral

Neutral for this company

4 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
59.39%
3yr Average
50.15%
5yr Average
37.99%
Net Profit Margin
Latest
21.15%
3yr Average
25.16%
5yr Average
21.09%
ROCE
Latest
38.25%
3yr Average
32.35%
5yr Average
27.35%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
6.24% (as of Jul 22)
Anti - Diabetes - Market Share
0.32% (as of Jul 22)
Anti-Infectives - Market Share
0.05% (as of Mar 19)
Antineo Plastic - Market Share
1.97% (as of Jul 22)
Cardiovascular - Market Share
0.55% (as of Mar 19)
Dermatology - Market Share
1.80% (as of Jul 22)
Gastro-Intestinal - Market Share
2.67% (as of Mar 19)
Neurological - Market Share
2.87% (as of Mar 19)
Pain - Market Share
1.60% (as of Dec 22)
Pharmaceutical Sector - Market Share
3.38% (as of Mar 19)
Respiratory - Market Share
0.10% (as of Mar 19)
Sex Stimulants - Market Share
20.16% (as of Jul 22)
Vaccines - Market Share
0.12% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Allegra
    Avil
    Combiflam
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis